{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T16:39:16Z","timestamp":1774543156745,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,25]]},"DOI":"10.7759\/cureus.45946","type":"journal-article","created":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T20:00:31Z","timestamp":1695672031000},"source":"Crossref","is-referenced-by-count":4,"title":["Efficacy of Adenosine Versus Verapamil in Terminating Acute Attacks of Paroxysmal Supraventricular Tachycardia: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Vamsi Krishna","family":"Pachchipulusu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yubraj","family":"Paudel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anandkumar","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beenish","family":"Najam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heet N","family":"Desai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janan","family":"Illango","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kofi D","family":"Seffah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahendar","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Namballa","family":"Naveen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Safeera","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000548","article-title":"2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practic","volume":"138","author":"Al-Khatib SM","year":"2018","unstructured":"Al-Khatib SM, Stevenson WG, Ackerman MJ, et al.. 2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practic. Circulation. 2018, 138:e210-71. 10.1161\/CIR.0000000000000548","journal-title":"Circulation"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ehj.2004.07.003","article-title":"Paroxysmal supraventricular tachycardia: preferential use of either adenosine or verapamil is dependent on the rate of tachycardia","volume":"25","author":"Steinbeck G","year":"2004","unstructured":"Steinbeck G, Reithmann C. Paroxysmal supraventricular tachycardia: preferential use of either adenosine or verapamil is dependent on the rate of tachycardia. Eur Heart J. 2004, 25:1277-8. 10.1016\/j.ehj.2004.07.003","journal-title":"Eur Heart J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2003.08.013","article-title":"ACC\/AHA\/ESC guidelines for the management of patients with supraventricular arrhythmias\u2217\u2014executive summary: a report of the American College of Cardiology\/American Heart Association task force on practice guidelines and the European Society of Cardiology committee for practice guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias)","volume":"42","year":"2003","unstructured":"ACC\/AHA\/ESC guidelines for the management of patients with supraventricular arrhythmias\u2217\u2014executive summary. a report of the American College of Cardiology\/American Heart Association task force on practice guidelines and the European Society of Cardiology committee for practice guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias). J Am Coll Cardiol. 2003, 42:1493-1531. 10.1016\/j.jacc.2003.08.013","journal-title":"J Am Coll Cardiol"},{"key":"ref4","article-title":"Adenosine vs. calcium channel blockers for supraventricular tachycardia","volume":"75","author":"Anugwom C","year":"2007","unstructured":"Anugwom C, Sulangi S, Dachs R. Adenosine vs. calcium channel blockers for supraventricular tachycardia. Am Fam Physician. 2007, 75:1653-4.","journal-title":"Am Fam Physician"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/s0735-1097(03)00987-2","article-title":"Termination of paroxysmal supraventricular tachycardia by tecadenoson (CVT-510), a novel A1-adenosine receptor agonist","volume":"42","author":"Prystowsky EN","year":"2003","unstructured":"Prystowsky EN, Niazi I, Curtis AB, et al.. Termination of paroxysmal supraventricular tachycardia by tecadenoson (CVT-510), a novel A1-adenosine receptor agonist. J Am Coll Cardiol. 2003, 42:1098-102. 10.1016\/s0735-1097(03)00987-2","journal-title":"J Am Coll Cardiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-113-2-104","article-title":"Adenosine for paroxysmal supraventricular tachycardia: dose ranging and comparison with verapamil. Assessment in placebo-controlled, multicenter trials. The Adenosine for PSVT Study Group","volume":"113","author":"DiMarco JP","year":"1990","unstructured":"DiMarco JP, Miles W, Akhtar M, et al.. Adenosine for paroxysmal supraventricular tachycardia: dose ranging and comparison with verapamil. Assessment in placebo-controlled, multicenter trials. The Adenosine for PSVT Study Group. Ann Intern Med. 1990, 113:104-10. 10.7326\/0003-4819-113-2-104","journal-title":"Ann Intern Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.resuscitation.2009.01.017","article-title":"Slow infusion of calcium channel blockers compared with intravenous adenosine in the emergency treatment of supraventricular tachycardia","volume":"80","author":"Lim SH","year":"2009","unstructured":"Lim SH, Anantharaman V, Teo WS, Chan YH. Slow infusion of calcium channel blockers compared with intravenous adenosine in the emergency treatment of supraventricular tachycardia. Resuscitation. 2009, 80:523-8. 10.1016\/j.resuscitation.2009.01.017","journal-title":"Resuscitation"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2022.06.005","article-title":"Rationale for and design of a multicenter, placebo-controlled, phase 3 study to assess efficacy and safety of intranasal etripamil for the conversion of paroxysmal supraventricular tachycardia","author":"Bruce S. Stambler","unstructured":"Bruce S. Stambler, Francis Plat, Philip T. Sager, et al.. Rationale for and design of a multicenter, placebo-controlled, phase 3 study to assess efficacy and safety of intranasal etripamil for the conversion of paroxysmal supraventricular tachycardia. 10.1016\/j.ahj.2022.06.005"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.160079","article-title":"Diagnosis and management of supraventricular tachycardias","volume":"188","author":"Bibas L","year":"2016","unstructured":"Bibas L, Levi M, Essebag V. Diagnosis and management of supraventricular tachycardias. CMAJ. 2016, 188:E466-73. 10.1503\/cmaj.160079","journal-title":"CMAJ"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4103\/sja.SJA_35_18","article-title":"Emergency department visits for paroxysmal supraventricular tachycardia in Saudi Arabia","volume":"12","author":"Althunayyan SM","year":"2018","unstructured":"Althunayyan SM, Khan AA, Samarkandi OA. Emergency department visits for paroxysmal supraventricular tachycardia in Saudi Arabia. Saudi J Anaesth. 2018, 12:521-8. 10.4103\/sja.SJA_35_18","journal-title":"Saudi J Anaesth"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ehj.2004.05.011","article-title":"Heart rate is a predictor of success in the treatment of adults with symptomatic paroxysmal supraventricular tachycardia","volume":"25","author":"Ballo P","year":"2004","unstructured":"Ballo P, Bernab\u00f2 D, Faraguti SA. Heart rate is a predictor of success in the treatment of adults with symptomatic paroxysmal supraventricular tachycardia. Eur Heart J. 2004, 25:1310-7. 10.1016\/j.ehj.2004.05.011","journal-title":"Eur Heart J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/s0735-1097(98)00015-1","article-title":"Clinical and electrophysiologic characteristics and long-term efficacy of slow-pathway catheter ablation in patients with spontaneous supraventricular tachycardia and dual atrioventricular node pathways without inducible tachycardia.","volume":"31","author":"Lin JL","year":"1998","unstructured":"Lin JL, Huang SS, Lai LP, Ko WC, Tseng YZ, Lien WP. Clinical and electrophysiologic characteristics and long-term efficacy of slow-pathway catheter ablation in patients with spontaneous supraventricular tachycardia and dual atrioventricular node pathways without inducible tachycardia.. J Am Coll Cardiol. 1998, 31:855-60. 10.1016\/s0735-1097(98)00015-1","journal-title":"J Am Coll Cardiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1542-474X.2009.00329.x","article-title":"Electrophysiologic characteristics of wide QRS complexes during pharmacologic termination of sustained supraventricular tachycardias with verapamil and adenosine: observations from electrophysiologic study","volume":"14","author":"T\u00fcrko\u011flu C","year":"2009","unstructured":"T\u00fcrko\u011flu C, \u00d6zt\u00fcrk M, Aliyev F, Firatli I, Incesoy N. Electrophysiologic characteristics of wide QRS complexes during pharmacologic termination of sustained supraventricular tachycardias with verapamil and adenosine: observations from electrophysiologic study. Ann Noninvasive Electrocardiol. 2009, 14:375-80. 10.1111\/j.1542-474X.2009.00329.x","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.15502","article-title":"In the line of treatment: a systematic review of paroxysmal supraventricular tachycardia","volume":"13","author":"Ahmad F","year":"2021","unstructured":"Ahmad F, Abu Sneineh M, Patel RS, et al.. In the line of treatment: a systematic review of paroxysmal supraventricular tachycardia. Cureus. 2021, 13:e15502. 10.7759\/cureus.15502","journal-title":"Cureus"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005154.pub4","article-title":"Adenosine versus intravenous calcium channel antagonists for supraventricular tachycardia","volume":"10","author":"Alabed S","year":"2017","unstructured":"Alabed S, Sabouni A, Providencia R, Atallah E, Qintar M, Chico TJ. Adenosine versus intravenous calcium channel antagonists for supraventricular tachycardia. Cochrane Database Syst Rev. 2017, 10:CD005154. 10.1002\/14651858.CD005154.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/MEJ.0b013e3283400ba2","article-title":"The relative efficacy of adenosine versus verapamil for the treatment of stable paroxysmal supraventricular tachycardia in adults: a meta-analysis","volume":"18","author":"Delaney B","year":"2011","unstructured":"Delaney B, Loy J, Kelly AM. The relative efficacy of adenosine versus verapamil for the treatment of stable paroxysmal supraventricular tachycardia in adults: a meta-analysis. Eur J Emerg Med. 2011, 18:148-52. 10.1097\/MEJ.0b013e3283400ba2","journal-title":"Eur J Emerg Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n160","article-title":"PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, Moher D, Bossuyt PM, et al.. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021, 372:n160. 10.1136\/bmj.n160","journal-title":"BMJ"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/161567-efficacy-of-adenosine-versus-verapamil-in-terminating-acute-attacks-of-paroxysmal-supraventricular-tachycardia-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:07:37Z","timestamp":1707509257000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/161567-efficacy-of-adenosine-versus-verapamil-in-terminating-acute-attacks-of-paroxysmal-supraventricular-tachycardia-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,25]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.45946","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,25]]}}}